A retrospective study on the use of albumin in the management of complications of decompensated cirrhosis from a major teaching hospital in Canada [0.03%]
加拿大一家大型教学医院在失代偿期肝硬化并发症管理中使用白蛋白的回顾性研究
Mai Kilany,Neha Tiwari,Florence Wong
Mai Kilany
Background: Various academic societies have recommended the use of albumin for managing ascites and its complications. This study aims to assess adherence to recommended albumin dosing and scheduling for large volume para...
Evaluation of a novel albumin platelet product (APP) fibrosis index and three non-invasive fibrosis indices in metabolic dysfunction-associated steatotic liver disease [0.03%]
新型白蛋白血小板产品(FIP)肝纤维化指数和3种非侵入性纤维化指数在代谢功能障碍相关脂肪型肝病中的评估
Amy Lou,Manal Elnenaei,Eric Liu et al.
Amy Lou et al.
Background: Albumin platelet product (APP) is a novel blood-based biomarker for liver fibrosis staging. This study evaluates APP's performance against Fibrosis-4 index (FIB-4), AST-platelet ratio index (APRI), and asparta...
Hepatitis B virus quantitative surface antigen levels differ by genotype [0.03%]
乙型肝炎病毒表面抗原定量水平不同的基因型的影响
Leon He,Alexa Keeshan,Christopher Georgi et al.
Leon He et al.
Background: Hepatitis B virus (HBV) antiviral treatment is guided by HBV DNA levels, liver enzyme values, and fibrosis score. Quantitative hepatitis B surface antigen (qHBsAg) may represent a more cost-effective and less ...
Delayed-onset drug-induced liver injury in a cystic fibrosis patient on long-term elexacaftor/ivacaftor/tezacaftor therapy: A case report and literature review [0.03%]
长期接受elexacaftor/ivacaftor/tezacaftor治疗的囊性纤维化患者的迟发型药物性肝损伤：一例报告及文献回顾
Ahmad F Alenezi,Yashasavi Sachar,Amindeep Sandhu
Ahmad F Alenezi
Background: Elexacaftor/tezacaftor/ivacaftor (ETI) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator widely used in patients with cystic fibrosis (CF), typically associated with mild, early onset l...
Post-liver transplant mortality in Canada: A retrospective analysis and quality assurance study in British Columbia [0.03%]
加拿大肝脏移植术后死亡率：不列颠哥伦比亚省的回顾性分析与质量保证研究
Nawaf T Aboalfaraj,Sedrah K Talab,Alexander R Hemy et al.
Nawaf T Aboalfaraj et al.
Background: Liver transplantation is a life-saving treatment for end-stage liver disease, significantly improving survival. In Canada, the number of liver transplants has increased, with British Columbia performing 107 tr...
Long-term clinical outcomes in lysosomal acid lipase deficiency: Fibrosis regression with sebelipase alfa therapy [0.03%]
溶酶体酸性脂酶缺乏的长期临床结果：Sebelipase Alfa治疗可逆转纤维化
Maria MacDonald,Grace Park,Scott Bray et al.
Maria MacDonald et al.
Background: Lysosomal acid lipase deficiency (LAL-D) is a rare autosomal recessive disorder caused by mutations in the LIPA gene, leading to accumulation of cholesterol esters and triglycerides, particularly in the liver ...
An association between antibiotic usage during pregnancy and the subsequent development of autoimmune hepatitis [0.03%]
孕期使用抗生素与自身免疫性肝炎发病之间的关联分析
Gerald Y Minuk,Lindsay E Nicolle,Marina Yogendran et al.
Gerald Y Minuk et al.
Background: Whether the incidence of autoimmune hepatitis (AIH) is higher in women prescribed antibiotics during pregnancy remains to be determined. Metho...
The emerging role of liver transplantation in metastatic colorectal cancer [0.03%]
肝移植在转移性结直肠癌中的作用不容忽视
Verena Rafael,Eric M Yoshida,Natasha Chandok
Verena Rafael
Colorectal cancer has a high global prevalence and is one of the leading causes of cancer-related death. Approximately one quarter of patients with colorectal cancer will develop metastases, most commonly to the liver, with the majority of ...
A milestone for the Canadian Liver Journal-building on our strengths, shaping our future [0.03%]
《加拿大肝脏杂志》的里程碑——发挥我们的优势，塑造我们的未来
Giada Sebastiani
Giada Sebastiani
Prevalence of neurodevelopmental disorders in children with chronic hepatitis C in British Columbia [0.03%]
英属哥伦比亚慢性丙型肝炎儿童神经发育障碍的患病率
Shreya B Kishore,Orlee Guttman
Shreya B Kishore
Background: Chronic hepatitis C (HCV) in children is primarily acquired through vertical transmission from an HCV-infected mother. The primary risk factor for chronic HCV in mothers is intravenous drug use, which, in preg...